Welcome : Guest

Amarantus Bioscience Holdings, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Amarantus Bioscience Holdings, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 70 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-65796
Price: $3500
Company Type: Public
Pages: 72
Date: November 2016
Market Data Tables: 70

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Biopharmaceuticals......3
Table 1: Biopharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Norditropin, NovoSeven, Turoctocog Alpha, and Others......3
Drugs......4
Table 2: Drugs Market by Region Worldwide (2015) - Percentage share Breakdown by Value Sales for Switzerland, US, Others Europe, and Rest of World......4
Table 3: Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Specialty Drugs, and Traditional Oral Drugs......5
Table 4: Spending on Drugs by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Canada, European Union, Japan, South Korea, US, and Others......6
Table 5: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, Monoclonal Antibodies and Other Classes......7
Table 6: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Brand, Generic and Others......8
Table 7: Drugs Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value for Biotechnology, Conventional and Other Unclassified......9
Table 8: Spending on Medicines by Region Worldwide (2015) - Percentage Share Breakdown by Value for Asia, Australia, Europe, Latin America, North America, and others......10
Table 9: Drug Market by Category in Asia-Pacific (2015) - Percentage Share Breakdown by Value Sales for Branded Generics, Originals and Un-Branded Generics......11
Table 10: Government Spending on Drugs by Category in Australia (2015) - Percentage Market Share Breakdown by Sales for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensives, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmologicals, Psychoanaleptics, Psycholeptics, and Others......12
Table 11: Government Spending on Drugs by Category in Australia (2015) - Percentage Market Share Breakdown by Volume for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensives, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmologicals, Psychoanaleptics, Psycholeptics, and Others......13
Table 12: Drugs Market by Category in Brazil (2015) - Percentage Share Breakdown by Volume for Generics and Others......14
Table 13: Drug Distribution Expenditure by Category in Canada (2015) - Percentage Share Breakdown by Value for Out of Pocket, Private Insurers and Public Payers......15
Table 14: Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Medical Devices, Over-the-counter Drugs, Prescription Drugs, Traditional Chinese Medicine, and Others......16
Table 15: Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Finished Drugs and Intermediate and Bulk Medicine......17
Table 16: Hospital Drug Market by Segment in China (2015) - Percentage Share Breakdown by Value for Anti-Infection, Cardio-Cerebral Vascular, Digest, Neurology, Oncology and Others......18
Table 17: Finished Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Antihypertensive Drugs, Digestive System Drugs, Liver Drugs and Others......19
Table 18: Patent Medicines Sales by Drugs in China (2015) - Percentage Share Breakdown by Value for Cardio-Cerebrovascular Drugs, Digestive System Drugs, Drugs for Deoplastic Diseases, Gynecological Drugs, Musculoskeletal Drugs, Nervous System Drugs, Respiratory System Drugs, Urinary System Drugs and Others......20
Table 19: Drugs Market by Category in France (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......21
Table 20: Formulations Sales by Category in India (2015) - Percentage Market Share Breakdown by Value for Anti Infective, Anti-diabetic, Central Nervous System (CNS), Cyclic Vomiting Syndrome (CVS), Gastrointestinal, Pain Management, and Others......22
Table 21: Drugs Market by Sector in Greece (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......23
Table 22: Ethical Drugs Revenues by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generic, Licensed and Unbranded Generic......24
Table 23: Drugs Market by Category in Italy (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......25
Table 24: Drugs Market by Category in Singapore (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......26
Table 25: Prescription Drugs Market in the US (2014) in US$ Million......27
Table 26: Critical Shortage Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Injectable, Orals, and Others......28
Table 27: Critical Shortage Drugs Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Anti-Infectives, Central Nervous System (CNS), Oncology, Pain, Vitamins and Minerals, and Others......29
Table 28: Critical Shortage Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Brand, Branded Generic, Generic, and Other Branded Generic......30
Table 29: Spending on Drugs by Category in the US (2015) - Percentage Share Breakdown by Value for Specialty Drugs and Traditional Drugs......31
Table 30: Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for Non-specialty and Specialty......32
Table 31: Drugs Sales by Type in the US (2015) - Percentage Share Breakdown by Value for Cefdinir, Cephalexin, Cofactor and Others......33
Table 32: A-2 Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Generic Doxycycline, Generic Minocycline, Generic Tetracycline, and Others......34
Table 33: Spending on Medicines by Category in the US (2015) - Percentage Share Breakdown by Value for Specialty Pharmaceuticals and Traditional Pharmaceuticals......35
Table 34: Spending on Medicines by Product in the US (2015) - Percentage Share Breakdown by Value for Injectable, Oral and Other Forms......36
Table 35: Spending on Medicines by Segment in the US (2015) - Percentage Share Breakdown by Value for Biologics and Small-Molecules......37
Table 36: Spending on Medicines by Source in the US (2015) - Percentage Share Breakdown by Value for Non-Retail and Retail......38
Table 37: Spending on Medicines by Type in the US (2015) - Percentage Share Breakdown by Value for Branded Generics, Brands and Unbranded Generics......39
Drugs of Abuse Testing (DOA) Testing......40
Table 38: Drugs of Abuse Testing (DOA) Testing by Technology Worldwide (2015) - Percentage Market Share Breakdown by Value for Heterogeneous, Homogenous, and POC/Rapid......40
Epilepsy Drugs......41
Table 39: Epilepsy Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Carbamazepine Generics, Depakote/ER Franchise (ABT), Depakote/ER Generics, Dilant in (PFE), Gabapent in Generics, Keppra Generics, Keppra/XR (UCB), Lamictal/XR (GSK), Lyrica (PFE), Trileptal (NVS), Vimpat (UCB), and Others......41
Ophthalmology......42
Table 40: Ophthalmology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Ophthalmic pharmaceuticals, Surgical, and Vision Care......42
Table 41: Ophthalmology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cataract & Vitreoretinal Surgery, Ophthalmic Lasers, and Vision Care......43
Neurology Devices......44
Table 42: Neurology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cerebrospinal Fluid Management, Interventional Neuroradiology, Neurostimulation, Neurosurgery, and Neurovascular Catheters......44
Table 43: Neurosurgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for < 15 Years, 15-44 Years, 45-64 Years, and 65+ Years......45
Diagnostic Testing......46
Table 44: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hospitals, Independent Labs, Physician Office Labs and Others......46
Table 45: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Volume Sales for Hospitals, Independent Labs, Physician Office Labs and Others......47
Table 46: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......48
Table 47: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......49
Table 48: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......50
Table 49: Diagnostic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Ambulatory Physician Services, and Hospital Services......51
Table 50: Diagnostic Testing Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, Inpatient, Outpatient, POLs, and Others......52
Table 51: Diagnostic Testing Sales by Category in the US (2015) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......53
Biotechnology......54
Table 52: Biotechnology Market by Category in China (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......54
Table 53: Biotechnology Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......55
Biotesting (Outsourced)......56
Table 54: Outsourced Biotesting Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Environment, Pharma and Others......56
Biotechnology Drugs......57
Table 55: Biotechnology Drugs by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Cell Therapy, Gene Therapy, Monoclonal Antibodies (MAB), Recombinant Hormones and Proteins, Vaccines, and Others......57
Biopharmaceuticals......58
Table 56: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......58
Table 57: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......59
Drugs......60
Table 58: Market Shares of Leading Drug Distributors Worldwide (2014) - Percentage Breakdown by Value for AmerisourceBergen Corporation, Express Scripts, McKesson Corporation, Metro Medical and Others......60
Table 59: Market Shares of Leading Drug Providers in the US (2014) - Percentage Breakdown by Value for Clearwater Paper Corporation and Other Private Label......61
Table 60: Market Shares of Leading Domestic Drugs Manufacturers in Vietnam (2015) - Percentage Share Breakdown by Volume for DHG Pharmaceutical JSC, Traphaco Joint Stock Company and Others......62
Ophthalmology Drugs......63
Table 61: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......63
Table 62: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......64
Diagnostic Imaging Equipment......65
Table 63: Market Shares of Leading Diagnostic Imaging Equipment Providers Worldwide (2015) - Percentage Breakdown by Value for Carestream Health, Inc., General Electric Co., Koninklijke Philips N.V., Siemens AG, Toshiba Corporation, and Others......65
Diagnostic Ultrasound......66
Table 64: Market Shares of Leading Diagnostic Ultrasound Manufacturers by Value Sales in Japan (2014) - Percentage Share Breakdown For GE Healthcare, Hitachi Medical Corporation, Philips Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, and Others......66
Diagnostic Testing......67
Table 65: Market Shares of Leading Diagnostic Testing Companies in the US (2015) - Percentage Share Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated and Others......67
Biotechnology......68
Table 66: Market Shares of Leading Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Value for Amgen, Inc., Merck KGaA, Monsanto Company, Roche Holding AG, Syngenta AG, and Others......68
Table 67: Market Shares of Leading Agricultural Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Research and Development (R&D) Expenditure for Bayer CropScience AG, Dow AgroSciences LLC, DuPont Pioneer, Monsanto Co., Inc., Syngenta AG and Others......69
Table 68: Market Shares of Leading Biotechnology Companies in China (2015) - Percentage Share Breakdown by Value for F. Hoffmann-La Roche Ltd., MERCK SERONO CO., LTD., Novo Nordisk A/S, Qilu Pharmaceutical Co., Ltd. and Others......70
Outsourced Biotesting......71
Table 69: Market Shares of Leading Outsourced Biotesting Companies Worldwide (2015) - Percentage Share Breakdown by Value for Eurofins Scientific, SGS S.A. and Others......71
Colony-Stimulating Factor (GCSF)......72
Table 70: Market Shares of Leading Granulocyte Colony-Stimulating Factor (GCSF) Companies in China (2014) - Percentage Share Breakdown by Value for Amoytop Biotech Co., Ltd., Harbin Pharmaceutical Group Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Qilu pharmaceutical Co., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd., and Others......72